: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Prostate Cancer

Free Subscription

Articles published in Prostate
Retrieve available abstracts of 308 articles:
HTML format
Text format

Single Articles

February 2012

SHEN J , Hruby GW, McKiernan JM, Gurvich I, et al
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer.
Prostate. 2012 Feb 1. doi: 10.1002/pros.22499.
PubMed Text format Related articles Abstract available

CHEN ZH , Zhang GL, Li HR, Luo JD, et al
A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Prostate. 2012 Feb 1. doi: 10.1002/pros.22495.
PubMed Text format Related articles Abstract available

January 2012

KAINI RR , Sillerud LO, Zhaorigetu S, Hu CA, et al
Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells.
Prostate. 2012 Jan 31. doi: 10.1002/pros.22489.
PubMed Text format Related articles Abstract available

FANG Y , Qiu Q, Domarkas J, Larroque-Lombard AL, et al
"Combi-targeting" mitozolomide: Conferring novel signaling inhibitory properties to an abandoned DNA alkylating agent in the treatment of advanced prostate cancer.
Prostate. 2012 Jan 30. doi: 10.1002/pros.22475.
PubMed Text format Related articles Abstract available

TSUI KH , Chang YL, Feng TH, Chang PL, et al
Glycoprotein transmembrane nmb: An androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.
Prostate. 2012 Jan 30. doi: 10.1002/pros.22494.
PubMed Text format Related articles Abstract available

YAO K , Youn H, Gao X, Huang B, et al
Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
Prostate. 2012 Jan 30. doi: 10.1002/pros.22493.
PubMed Text format Related articles Abstract available

IDE H , Lu Y, Yu J, China T, et al
Testosterone promotes DNA damage response under oxidative stress in prostate cancer cell lines.
Prostate. 2012 Jan 30. doi: 10.1002/pros.22492.
PubMed Text format Related articles Abstract available

SUNG HH , Jeong BC, Seo SI, Jeon SS, et al
Seven years of experience with high-intensity focused ultrasound for prostate cancer: Advantages and limitations.
Prostate. 2012 Jan 17. doi: 10.1002/pros.22491.
PubMed Text format Related articles Abstract available

SALEEM A , Dvorzhinski D, Santanam U, Mathew R, et al
Effect of dual inhibition of apoptosis and autophagy in prostate cancer.
Prostate. 2012 Jan 12. doi: 10.1002/pros.22487.
PubMed Text format Related articles Abstract available

GOODMAN M , Ward KC, Osunkoya AO, Datta MW, et al
Frequency and determinants of disagreement and error in gleason scores: A population-based study of prostate cancer.
Prostate. 2012 Jan 6. doi: 10.1002/pros.22484.
PubMed Text format Related articles Abstract available

MILES FL , Tung NS, Aguiar AA, Kurtoglu S, et al
Increased TGF-beta1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.
Prostate. 2012 Jan 6. doi: 10.1002/pros.22482.
PubMed Text format Related articles Abstract available

TERRACCIANO D , Bruzzese D, Ferro M, Mazzarella C, et al
Preoperative insulin-like growth factor-binding protein-3 (IGFBP-3) blood level predicts gleason sum upgrading.
Prostate. 2012;72:100-7.
PubMed Text format Related articles Abstract available

MEYER TE , Chu LW, Li Q, Yu K, et al
The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.
Prostate. 2012;72:65-71.
PubMed Text format Related articles Abstract available

December 2011

KOMATSU S , Hara N, Ishizaki F, Nishiyama T, et al
Altered association of interleukin-6 with sex steroids in lipid metabolism disorder in men with prostate cancer receiving androgen deprivation therapy.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22471.
PubMed Text format Related articles Abstract available

OUZAID I , Yates DR, Hupertan V, Mozer P, et al
A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22470.
PubMed Text format Related articles Abstract available

TAKEUCHI I , Takaha N, Nakamura T, Hongo F, et al
High mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independence in prostate cancer cells.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22460.
PubMed Text format Related articles Abstract available

NAJY AJ , Jung YS, Won JJ, Conley-Lacomb MK, et al
Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22481.
PubMed Text format Related articles Abstract available

SPANS L , Atak ZK, Van Nieuwerburgh F, Deforce D, et al
Variations in the exome of the LNCaP prostate cancer cell line.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22480.
PubMed Text format Related articles Abstract available

GE D , Gao AC, Zhang Q, Liu S, et al
LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22479.
PubMed Text format Related articles Abstract available

LOCKE JA , Zafarana G, Malloff CA, Lam WL, et al
Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancer.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22478.
PubMed Text format Related articles Abstract available

GIUSIANO S , Baylot V, Andrieu C, Fazli L, et al
TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22477.
PubMed Text format Related articles Abstract available

MATOKA DJ , Yao V, Harya DS, Gregg JL, et al
Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.
Prostate. 2011 Dec 27. doi: 10.1002/pros.22472.
PubMed Text format Related articles Abstract available

BARRON N , Keenan J, Gammell P, Martinez VG, et al
Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22469.
PubMed Text format Related articles Abstract available

HONG SK , Oh JJ, Lee S, Lee HM, et al
Association of 5alpha-reductase inhibitor use and pathological features of prostate cancer in men undergoing radical prostatectomy.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22468.
PubMed Text format Related articles Abstract available

SINNOTT M , Falzarano SM, Hernandez AV, Jones JS, et al
Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22467.
PubMed Text format Related articles Abstract available

XU B , Wang N, Wang X, Tong N, et al
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22466.
PubMed Text format Related articles Abstract available

VAN NESTE L , Herman JG, Otto G, Bigley JW, et al
The Epigenetic promise for prostate cancer diagnosis.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22459.
PubMed Text format Related articles Abstract available

SAKAO K , Desineni S, Hahm ER, Singh SV, et al
Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo.
Prostate. 2011 Dec 7. doi: 10.1002/pros.22457.
PubMed Text format Related articles Abstract available

AVGERIS M , Stravodimos K, Scorilas A
Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
Prostate. 2011;71:1780-9.
PubMed Text format Related articles Abstract available

HALTER RJ , Schned AR, Heaney JA, Hartov A, et al
Passive bioelectrical properties for assessing high- and low-grade prostate adenocarcinoma.
Prostate. 2011;71:1759-67.
PubMed Text format Related articles Abstract available

ZHANG C , Montironi R, MacLennan GT, Lopez-Beltran A, et al
Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Prostate. 2011;71:1746-51.
PubMed Text format Related articles Abstract available

November 2011

OLEKSOWICZ L , Liu Y, Bracken RB, Gaitonde K, et al
Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Prostate. 2011 Nov 29. doi: 10.1002/pros.22463.
PubMed Text format Related articles Abstract available

LUTJE S , Boerman OC, van Rij CM, Sedelaar M, et al
Prospects in radionuclide imaging of prostate cancer.
Prostate. 2011 Nov 29. doi: 10.1002/pros.22462.
PubMed Text format Related articles Abstract available

SUN T , Yang M, Chen S, Balk S, et al
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer.
Prostate. 2011 Nov 29. doi: 10.1002/pros.22456.
PubMed Text format Related articles Abstract available

KAWATA H , Shimada N, Kamiakito T, Komatsu K, et al
RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy.
Prostate. 2011 Nov 14. doi: 10.1002/pros.21511.
PubMed Text format Related articles Abstract available

WAYNER EA , Quek SI, Ahmad R, Ho ME, et al
Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.
Prostate. 2011 Nov 9. doi: 10.1002/pros.21508.
PubMed Text format Related articles Abstract available

MASCARENO EJ , Belashov I, Siddiqui MA, Liu F, et al
Hexim-1 modulates androgen receptor and the TGF-beta signaling during the progression of prostate cancer.
Prostate. 2011 Nov 9. doi: 10.1002/pros.21510.
PubMed Text format Related articles Abstract available

KOBAYASHI M , Huang Y, Jin C, Luo Y, et al
FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells.
Prostate. 2011;71:1691-700.
PubMed Text format Related articles Abstract available

HU R , Isaacs WB, Luo J
A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities.
Prostate. 2011;71:1656-67.
PubMed Text format Related articles Abstract available

TAI S , Sun Y, Squires JM, Zhang H, et al
PC3 is a cell line characteristic of prostatic small cell carcinoma.
Prostate. 2011;71:1668-79.
PubMed Text format Related articles Abstract available

BHUSARI S , Yang B, Kueck J, Huang W, et al
Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
Prostate. 2011;71:1621-30.
PubMed Text format Related articles Abstract available

WILLIAMS SA , Jelinek CA, Litvinov I, Cotter RJ, et al
Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.
Prostate. 2011;71:1595-607.
PubMed Text format Related articles Abstract available

October 2011

TERADA N , Shiraishi T, Zeng Y, Mooney SM, et al
Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.
Prostate. 2011 Oct 24. doi: 10.1002/pros.21501.
PubMed Text format Related articles Abstract available

TWIDDY AL , Cox ME, Wasan KM
Knockdown of scavenger receptor class B Type I reduces prostate specific antigen secretion and viability of prostate cancer cells.
Prostate. 2011 Oct 24. doi: 10.1002/pros.21499.
PubMed Text format Related articles Abstract available

RABIEN A , Ergun B, Erbersdobler A, Jung K, et al
RECK overexpression decreases invasive potential in prostate cancer cells.
Prostate. 2011 Oct 24. doi: 10.1002/pros.21498.
PubMed Text format Related articles Abstract available

FLEISCHMANN A , Huland H, Mirlacher M, Wilczak W, et al
Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.
Prostate. 2011 Oct 24. doi: 10.1002/pros.21504.
PubMed Text format Related articles Abstract available

JENNBACKEN K , Welen K, Olsson A, Axelsson B, et al
Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050).
Prostate. 2011 Oct 5. doi: 10.1002/pros.21495.
PubMed Text format Related articles Abstract available

HENRY JY , Lu L, Adams M, Meyer B, et al
Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
Prostate. 2011 Oct 3. doi: 10.1002/pros.21488.
PubMed Text format Related articles Abstract available

September 2011

BRIGANTI A , Tutolo M, Suardi N, Gallina A, et al
There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. Implications for focal therapies.
Prostate. 2011 Sep 30. doi: 10.1002/pros.21497.
PubMed Text format Related articles Abstract available

STAHL PR , Kilgue A, Tennstedt P, Minner S, et al
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.
Prostate. 2011 Sep 28. doi: 10.1002/pros.21492.
PubMed Text format Related articles Abstract available

SAXENA P , Trerotola M, Wang T, Li J, et al
PSA regulates androgen receptor expression in prostate cancer cells.
Prostate. 2011 Sep 28. doi: 10.1002/pros.21482.
PubMed Text format Related articles Abstract available

XU D , Lin TH, Zhang C, Tsai YC, et al
The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.
Prostate. 2011 Sep 19. doi: 10.1002/pros.21474.
PubMed Text format Related articles Abstract available

LE PAGE C , Koumakpayi IH, Peant B, Delvoye N, et al
ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells.
Prostate. 2011 Sep 19. doi: 10.1002/pros.21483.
PubMed Text format Related articles Abstract available

NOGUCHI M , Moriya F, Suekane S, Matsuoka K, et al
Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.
Prostate. 2011 Sep 19. doi: 10.1002/pros.21485.
PubMed Text format Related articles Abstract available

DONNA LD , Lagadec C, Pajonk F
Radioresistance of prostate cancer cells with low proteasome activity.
Prostate. 2011 Sep 19. doi: 10.1002/pros.21489.
PubMed Text format Related articles Abstract available

PANDHARE-DASH J , Mantri CK, Gong Y, Chen Z, et al
XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).
Prostate. 2011 Sep 19. doi: 10.1002/pros.21491.
PubMed Text format Related articles Abstract available

RONALD S , Sunavala-Dossabhoy G, Adams L, Williams B, et al
The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair.
Prostate. 2011;71:1367-73.
PubMed Text format Related articles Abstract available

WANG L , Zhang J, Zhang Y, Nkhata K, et al
Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
Prostate. 2011;71:1429-40.
PubMed Text format Related articles Abstract available

BARBORO P , Repaci E, Ferrari N, Rubagotti A, et al
Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines.
Prostate. 2011;71:1466-79.
PubMed Text format Related articles Abstract available

XU T , He K, Wang L, Goldkorn A, et al
Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.
Prostate. 2011;71:1390-400.
PubMed Text format Related articles Abstract available

FRIDMAN E , Daya D, Srigley J, Whelan KF, et al
Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique.
Prostate. 2011;71:1374-81.
PubMed Text format Related articles Abstract available

VAINIO P , Wolf M, Edgren H, He T, et al
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.
Prostate. 2011 Sep 14. doi: 10.1002/pros.21487.
PubMed Text format Related articles Abstract available

RAY M , Hostetter DR, Loeb CR, Simko J, et al
Inhibition of Granzyme B by PI-9 protects prostate cancer cells from apoptosis.
Prostate. 2011 Sep 14. doi: 10.1002/pros.21486.
PubMed Text format Related articles Abstract available

August 2011

FRIEDMAN AE
Comment on "Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer" by Hsieh et al.
Prostate. 2011 Aug 31. doi: 10.1002/pros.21480.
PubMed Text format Related articles

ANIDJAR M , Scarlata E, Cury FL, Rocha J, et al
Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.
Prostate. 2011 Aug 31. doi: 10.1002/pros.21479.
PubMed Text format Related articles Abstract available

COLOMBEL M , Eaton CL, Hamdy F, Ricci E, et al
Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases.
Prostate. 2011 Aug 31. doi: 10.1002/pros.21473.
PubMed Text format Related articles Abstract available

DALRYMPLE SL , Becker RE, Zhou H, Deweese TL, et al
Tasquinimod prevents the angiogenic rebound induced by fractionated radiation resulting in an enhanced therapeutic response of prostate cancer xenografts.
Prostate. 2011 Aug 11. doi: 10.1002/pros.21467.
PubMed Text format Related articles Abstract available

ALLIOLI N , Vincent S, Vlaeminck-Guillem V, Decaussin-Petrucci M, et al
TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration.
Prostate. 2011;71:1239-50.
PubMed Text format Related articles Abstract available

XU S , Weihua Z
Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin.
Prostate. 2011;71:1216-24.
PubMed Text format Related articles Abstract available

LAWRENCE MG , Margaryan NV, Loessner D, Collins A, et al
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.
Prostate. 2011;71:1198-209.
PubMed Text format Related articles Abstract available

HUANG SP , Bao BY, Wu MT, Choueiri TK, et al
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy.
Prostate. 2011;71:1189-97.
PubMed Text format Related articles Abstract available

GHADERSOHI A , Sharma S, Zhang S, Azrak RG, et al
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
Prostate. 2011;71:1178-88.
PubMed Text format Related articles Abstract available

WANG F , Zou YF, Feng XL, Su H, et al
CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies.
Prostate. 2011;71:1167-77.
PubMed Text format Related articles Abstract available

GAN L , Wang J, Xu H, Yang X, et al
Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
Prostate. 2011;71:1158-66.
PubMed Text format Related articles Abstract available

SHIMOJO H , Kobayashi M, Kamigaito T, Shimojo Y, et al
Reduced glycosylation of alpha-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.
Prostate. 2011;71:1151-7.
PubMed Text format Related articles Abstract available

TOMIC TT , Gustavsson H, Wang W, Jennbacken K, et al
Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2.
Prostate. 2011 Aug 1. doi: 10.1002/pros.21472.
PubMed Text format Related articles Abstract available

STENSVOLD A , Dahl AA, Brennhovd B, Cvancarova M, et al
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones.
Prostate. 2011 Aug 1. doi: 10.1002/pros.21470.
PubMed Text format Related articles Abstract available

ENDOH K , Nishi M, Ishiguro H, Uemura H, et al
Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.
Prostate. 2011 Aug 1. doi: 10.1002/pros.21466.
PubMed Text format Related articles Abstract available

July 2011

ELLIS L , Lehet K, Ramakrishnan S, Adelaiye R, et al
Development of a castrate resistant transplant tumor model of prostate cancer.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21465.
PubMed Text format Related articles Abstract available

FAJARDO AM , Mackenzie DA, Ji M, Deck LM, et al
The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21464.
PubMed Text format Related articles Abstract available

BASU A , Drame A, Munoz R, Gijsbers R, et al
Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21463.
PubMed Text format Related articles Abstract available

ZHENG J , Liu F, Lin X, Wang X, et al
Predictive Performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21462.
PubMed Text format Related articles Abstract available

SOOD AK , Kim H, Geradts J
PDEF in Prostate Cancer.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21461.
PubMed Text format Related articles Abstract available

DONINI M , Marongiu L, Fontana E, Dusi S, et al
Prostate carcinoma cells LNCaP and glucan cooperate in induction of cytokine synthesis by dendritic cells: Effect on natural killer cells and CD4(+) lymphocytes activation.
Prostate. 2011 Jul 27. doi: 10.1002/pros.21460.
PubMed Text format Related articles Abstract available

BRUNO TC , Rothwell C, Grosso JF, Getnet D, et al
Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.
Prostate. 2011 Jul 14. doi: 10.1002/pros.21453.
PubMed Text format Related articles Abstract available

FROMONT G , Godet J, Pires C, Yacoub M, et al
Biological significance of perineural invasion (PNI) in Prostate cancer.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21456.
PubMed Text format Related articles Abstract available

NAIKI T , Asamoto M, Toyoda-Hokaiwado N, Naiki-Ito A, et al
Organ specific Gst-pi expression of the metastatic androgen independent prostate cancer cells in nude mice.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21455.
PubMed Text format Related articles Abstract available

TAYLOR RM , Severns V, Brown DC, Bisoffi M, et al
Prostate cancer targeting motifs: Expression of alpha(nu) beta(3) , neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21454.
PubMed Text format Related articles Abstract available

ZABRANSKY DJ , Smith HA, Thoburn CJ, Zahurak M, et al
Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21449.
PubMed Text format Related articles Abstract available

LU L , Cancel-Tassin G, Valeri A, Cussenot O, et al
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21443.
PubMed Text format Related articles Abstract available

GEORGE D , Moul JW
Emerging treatment options for patients with castration-resistant prostate cancer.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21435.
PubMed Text format Related articles Abstract available

MASSONER P , Lueking A, Goehler H, Hopfner A, et al
Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Prostate. 2011 Jul 11. doi: 10.1002/pros.21444.
PubMed Text format Related articles Abstract available

SHAO P , Ding Q, Qin C, Wang M, et al
Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Prostate. 2011;71:1122-30.
PubMed Text format Related articles Abstract available

HSIEH JT , Chen SC, Yu HJ, Chang HC, et al
Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer.
Prostate. 2011;71:1115-21.
PubMed Text format Related articles Abstract available

CANACCI AM , Izumi K, Zheng Y, Gordetsky J, et al
Expression of semenogelins I and II and its prognostic significance in human prostate cancer.
Prostate. 2011;71:1108-14.
PubMed Text format Related articles Abstract available

VO BT , Khan SA
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: Autocrine effects on cell proliferation and migration.
Prostate. 2011;71:1084-96.
PubMed Text format Related articles Abstract available

GREINER M , Kreutzer B, Lang S, Jung V, et al
Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.
Prostate. 2011;71:1074-83.
PubMed Text format Related articles Abstract available

GOUAZE-ANDERSSON V , Flowers M, Karimi R, Fabrias G, et al
Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.
Prostate. 2011;71:1064-73.
PubMed Text format Related articles Abstract available

OKOBIA MN , Zmuda JM, Ferrell RE, Patrick AL, et al
Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.
Prostate. 2011;71:1054-63.
PubMed Text format Related articles Abstract available

BLANN AD , Balakrishnan B, Shantsila E, Ryan P, et al
Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers.
Prostate. 2011;71:1047-53.
PubMed Text format Related articles

GODOY A , Kawinski E, Li Y, Oka D, et al
5alpha-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression.
Prostate. 2011;71:1033-46.
PubMed Text format Related articles Abstract available

LIU M , Suzuki M, Arai T, Sawabe M, et al
A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
Prostate. 2011;71:1023-32.
PubMed Text format Related articles Abstract available

June 2011

BARRY M , Dhillon PK, Stampfer MJ, Perner S, et al
alpha-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study.
Prostate. 2011 Jun 28. doi: 10.1002/pros.21432.
PubMed Text format Related articles Abstract available

KEIZMAN D , Huang P, Carducci MA, Eisenberger MA, et al
Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: Clinical factors associated with PSA response and disease progression.
Prostate. 2011 Jun 17. doi: 10.1002/pros.21447.
PubMed Text format Related articles Abstract available

THOMAS LN , Morehouse TJ, Too CK
Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
Prostate. 2011 Jun 17. doi: 10.1002/pros.21446.
PubMed Text format Related articles Abstract available

PI M , Quarles LD
GPRC6A regulates prostate cancer progression.
Prostate. 2011 Jun 16. doi: 10.1002/pros.21442.
PubMed Text format Related articles Abstract available

ZHU Y , Tummala R, Liu C, Nadiminty N, et al
RhoGDIalpha suppresses growth and survival of prostate cancer cells.
Prostate. 2011 Jun 16. doi: 10.1002/pros.21441.
PubMed Text format Related articles Abstract available

SADEGHI N , Badalato GM, Hruby G, Grann V, et al
Does absolute neutrophil count predict high tumor grade in African-American men with prostate cancer?
Prostate. 2011 Jun 16. doi: 10.1002/pros.21440.
PubMed Text format Related articles Abstract available

YE X , Lee YC, Choueiri M, Chu K, et al
Aberrant expression of katanin p60 in prostate cancer bone metastasis.
Prostate. 2011 Jun 16. doi: 10.1002/pros.21431.
PubMed Text format Related articles Abstract available

ZHENG Y , Zhou H, Ooi LL, Snir AD, et al
Vitamin D deficiency promotes prostate cancer growth in bone.
Prostate. 2011;71:1012-21.
PubMed Text format Related articles

CHORNOKUR G , Dalton K, Borysova ME, Kumar NB, et al
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.
Prostate. 2011;71:985-97.
PubMed Text format Related articles

HOSHINO K , Ishiguro H, Teranishi J, Yoshida S, et al
Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.
Prostate. 2011;71:964-75.
PubMed Text format Related articles

LU Y , Zhang Z, Yu H, Zheng SL, et al
Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.
Prostate. 2011;71:955-63.
PubMed Text format Related articles

KIM J , Koyanagi T, Mochly-Rosen D
PKCdelta activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells.
Prostate. 2011;71:946-54.
PubMed Text format Related articles

SAMUEL-MENDELSOHN S , Inbar M, Weiss-Messer E, Niv-Spector L, et al
Leptin signaling and apoptotic effects in human prostate cancer cell lines.
Prostate. 2011;71:929-45.
PubMed Text format Related articles

FELDMANN A , Stamova S, Bippes CC, Bartsch H, et al
Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats.
Prostate. 2011;71:998-1011.
PubMed Text format Related articles Abstract available

MORGAN K , Stavrou E, Leighton SP, Miller N, et al
Elevated GnRH receptor expression plus GnRH agonist treatment inhibits the growth of a subset of papillomavirus 18-immortalized human prostate cells.
Prostate. 2011;71:915-28.
PubMed Text format Related articles Abstract available

LU Y , Sun J, Kader AK, Kim ST, et al
Association of prostate cancer risk with snps in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
Prostate. 2011 Jun 10. doi: 10.1002/pros.21439.
PubMed Text format Related articles Abstract available

AGHAEI M , Karami-Tehrani F, Panjehpour M, Salami S, et al
Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
Prostate. 2011 Jun 8. doi: 10.1002/pros.21438.
PubMed Text format Related articles Abstract available

MAEDA T , Murata M, Chiba H, Takasawa A, et al
Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Prostate. 2011 Jun 8. doi: 10.1002/pros.21436.
PubMed Text format Related articles Abstract available

YAN J , Xie B, Capodice JL, Katz AE, et al
Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
Prostate. 2011 Jun 8. doi: 10.1002/pros.21426.
PubMed Text format Related articles Abstract available

ALMASI CE , Brasso K, Iversen P, Pappot H, et al
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer.
Prostate. 2011;71:899-907.
PubMed Text format Related articles Abstract available

PINSKI J , Xiong S, Wang Q, Stanczyk F, et al
Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer.
Prostate. 2011;71:892-8.
PubMed Text format Related articles Abstract available

XU Z , Bensen JT, Smith GJ, Mohler JL, et al
GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).
Prostate. 2011;71:881-91.
PubMed Text format Related articles Abstract available

BARNABAS N , Xu L, Savera A, Hou Z, et al
Chromosome 8 markers of metastatic prostate cancer in African American men: Gain of the MIR151 gene and loss of the NKX3-1 gene.
Prostate. 2011;71:857-71.
PubMed Text format Related articles Abstract available

APARICIO A , Tzelepi V, Araujo JC, Guo CC, et al
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles.
Prostate. 2011;71:846-56.
PubMed Text format Related articles Abstract available

ZHU Q , Yang J, Han S, Liu J, et al
Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
Prostate. 2011;71:835-45.
PubMed Text format Related articles Abstract available

GONZALEZ-MORENO O , Boque N, Redrado M, Milagro F, et al
Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage.
Prostate. 2011;71:824-34.
PubMed Text format Related articles Abstract available

PARK MH , Choi MS, Kwak DH, Oh KW, et al
Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB.
Prostate. 2011;71:801-12.
PubMed Text format Related articles Abstract available

GOEPFERT C , Gazdhar A, Frey FJ, Frey BM, et al
Effect of electroporation-mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID mice.
Prostate. 2011;71:872-80.
PubMed Text format Related articles Abstract available

ABEDINPOUR P , Baron VT, Welsh J, Borgstrom P, et al
Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo.
Prostate. 2011;71:813-23.
PubMed Text format Related articles Abstract available

May 2011

JIANG J , Pan Y, Regan KM, Wu C, et al
Androgens repress expression of the f-box protein Skp2 via p107 dependent and independent mechanisms in LNCaP prostate cancer cells.
Prostate. 2011 May 31. doi: 10.1002/pros.21430.
PubMed Text format Related articles Abstract available

DIMONTE G , Bergstralh EJ, Bolander ME, Karnes RJ, et al
Use of tumor dynamics to clarify the observed variability among biochemical recurrence nomograms for prostate cancer.
Prostate. 2011 May 31. doi: 10.1002/pros.21429.
PubMed Text format Related articles Abstract available

ZHAO Z , Ma W, Zeng G, Qi D, et al
Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy.
Prostate. 2011 May 31. doi: 10.1002/pros.21428.
PubMed Text format Related articles Abstract available

KOOCHEKPOUR S , Hu S, Vellasco-Gonzalez C, Bernardo R, et al
Serum prosaposin levels are increased in patients with advanced prostate cancer.
Prostate. 2011 May 31. doi: 10.1002/pros.21427.
PubMed Text format Related articles Abstract available

JOSHUA AM , Shen E, Yoshimoto M, Marrano P, et al
Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies.
Prostate. 2011;71:778-90.
PubMed Text format Related articles Abstract available

BLOCK AS , Saraswati S, Lichti CF, Mahadevan M, et al
Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen.
Prostate. 2011;71:711-21.
PubMed Text format Related articles Abstract available

TUNG WL , Wang Y, Gout PW, Liu DM, et al
Use of irinotecan for treatment of small cell carcinoma of the prostate.
Prostate. 2011;71:675-81.
PubMed Text format Related articles Abstract available

SHUI IM , Stark JR, Penney KL, Schumacher FR, et al
Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
Prostate. 2011 May 11. doi: 10.1002/pros.21423.
PubMed Text format Related articles Abstract available

MIYATA Y , Watanabe SI, Matsuo T, Hayashi T, et al
Pathological significance and predictive value for biochemical recurrence of c-Fes expression in prostate cancer.
Prostate. 2011 May 11. doi: 10.1002/pros.21422.
PubMed Text format Related articles Abstract available

ZHU H , Zhao J, Zhu B, Collazo J, et al
EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer.
Prostate. 2011 May 11. doi: 10.1002/pros.21408.
PubMed Text format Related articles Abstract available

AUMAYR K , Breitegger M, Mazal PR, Koller A, et al
Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients.
Prostate. 2011 May 11. doi: 10.1002/pros.21396.
PubMed Text format Related articles Abstract available

BRIGANTI A , Suardi N, Capogrosso P, Passoni N, et al
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
Prostate. 2011 May 2. doi: 10.1002/pros.21420.
PubMed Text format Related articles

MERRILL RM , Sloan A
Risk-adjusted incidence rates for prostate cancer in the United States.
Prostate. 2011 May 2. doi: 10.1002/pros.21419.
PubMed Text format Related articles

TANG P , Du W, Xie K, Fu J, et al
Characteristics of baseline PSA and PSA velocity in young men without prostate cancer: Racial differences.
Prostate. 2011 May 2. doi: 10.1002/pros.21418.
PubMed Text format Related articles

WOLTERS T , Montironi R, Mazzucchelli R, Scarpelli M, et al
Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy.
Prostate. 2011 May 2. doi: 10.1002/pros.21415.
PubMed Text format Related articles

LANGE EM , Salinas CA, Zuhlke KA, Ray AM, et al
Early onset prostate cancer has a significant genetic component.
Prostate. 2011 May 2. doi: 10.1002/pros.21414.
PubMed Text format Related articles

HALL MA , Kwon S, Robinson H, Lachance PA, et al
Imaging prostate cancer lymph node metastases with a multimodality contrast agent.
Prostate. 2011 May 2. doi: 10.1002/pros.21413.
PubMed Text format Related articles

GIUSIANO S , Garcia S, Andrieu C, Dusetti NJ, et al
TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse.
Prostate. 2011 May 2. doi: 10.1002/pros.21412.
PubMed Text format Related articles

SUN M , Liu C, Nadiminty N, Lou W, et al
Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion.
Prostate. 2011 May 2. doi: 10.1002/pros.21409.
PubMed Text format Related articles

MARIAN CO , Yang L, Zou YS, Gore C, et al
Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line.
Prostate. 2011;71:626-36.
PubMed Text format Related articles Abstract available

April 2011

SIDANA A , Hernandez DJ, Feng Z, Partin AW, et al
Treatment decision-making for localized prostate cancer: What younger men choose and why.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21406.
PubMed Text format Related articles

HONG SK , Oh JJ, Byun SS, Hwang SI, et al
Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (>/=12)-core prostate biopsy.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21405.
PubMed Text format Related articles

RODRIGUEZ-BERRIGUETE G , Fraile B, Paniagua R, Aller P, et al
Expression of NF-kappaB-related proteins and their modulation during TNF-alpha-provoked apoptosis in prostate cancer cells.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21404.
PubMed Text format Related articles

SZULKIN R , Holmberg E, Stattin P, Xu J, et al
Prostate cancer risk variants are not associated with disease progression.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21403.
PubMed Text format Related articles

LEWINSHTEIN D , Teng B, Valencia A, Gibbons R, et al
The Association between pre-operative PSA and prostate cancer-specific mortality in patients with long-term follow-up after radical prostatectomy.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21402.
PubMed Text format Related articles

CHIRIVA-INTERNATI M , Yu Y, Mirandola L, D'Cunha N, et al
Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21400.
PubMed Text format Related articles

FACHAL L , Gomez-Caamano A, Celeiro-Munoz C, Peleteiro P, et al
BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21394.
PubMed Text format Related articles

RIGAU M , Ortega I, Mir MC, Ballesteros C, et al
A Three-Gene panel on urine increases PSA specificity in the detection of prostate cancer.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21390.
PubMed Text format Related articles

SHIGEMURA K , Huang WC, Li X, Zhau HE, et al
Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.
Prostate. 2011 Apr 25. doi: 10.1002/pros.21388.
PubMed Text format Related articles

CHANG CC , Ho SC, Chiu HF, Yang CY, et al
Statins increase the risk of prostate cancer: A population-based case-control study.
Prostate. 2011 Apr 7. doi: 10.1002/pros.21401.
PubMed Text format Related articles Abstract available

SANCHEZ C , Mercado A, Contreras HR, Mendoza P, et al
Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins.
Prostate. 2011 Apr 7. doi: 10.1002/pros.21398.
PubMed Text format Related articles Abstract available

REDDY KR , Guan Y, Qin G, Zhou Z, et al
Combined treatment targeting HIF-1alpha and Stat3 is a potent strategy for prostate cancer therapy.
Prostate. 2011 Apr 7. doi: 10.1002/pros.21397.
PubMed Text format Related articles Abstract available

HEINRICH E , Trojan L, Friedrich D, Voss M, et al
Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin - impact on angiogenesis and clinical follow-up.
Prostate. 2011 Apr 7. doi: 10.1002/pros.21392.
PubMed Text format Related articles Abstract available

FOSTER WR , Car BD, Shi H, Levesque PC, et al
Drug safety is a barrier to the discovery and development of new androgen receptor antagonists.
Prostate. 2011;71:480-8.
PubMed Text format Related articles Abstract available

BERTILSSON H , Angelsen A, Viset T, Skogseth H, et al
A new method to provide a fresh frozen prostate slice suitable for gene expression study and MR spectroscopy.
Prostate. 2011;71:461-9.
PubMed Text format Related articles Abstract available

March 2011

TURNER DP , Findlay VJ, Moussa O, Semenchenko VI, et al
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Prostate. 2011 Mar 28. doi: 10.1002/pros.21389.
PubMed Text format Related articles Abstract available

GRAVINA GL , Marampon F, Piccolella M, Biordi L, et al
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib.
Prostate. 2011 Mar 28. doi: 10.1002/pros.21363.
PubMed Text format Related articles Abstract available

YIP PY , Kench JG, Rasiah KK, Benito RP, et al
Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.
Prostate. 2011 Mar 22. doi: 10.1002/pros.21381.
PubMed Text format Related articles Abstract available

KEIZMAN D , Huang P, Antonarakis ES, Sinibaldi V, et al
The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation.
Prostate. 2011 Mar 22. doi: 10.1002/pros.21377.
PubMed Text format Related articles Abstract available

ERICSON KR , Simons JW, Soule HR
The 17th Annual Prostate Cancer Foundation scientific retreat: Meeting report.
Prostate. 2011 Mar 10. doi: 10.1002/pros.21378.
PubMed Text format Related articles Abstract available

SWANSON TA , Krueger SA, Galoforo S, Thibodeau BJ, et al
TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
Prostate. 2011 Mar 10. doi: 10.1002/pros.21371.
PubMed Text format Related articles Abstract available

LEE GT , Kwon SJ, Lee JH, Jeon SS, et al
Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.
Prostate. 2011 Mar 3. doi: 10.1002/pros.21369.
PubMed Text format Related articles Abstract available

BRUSA D , Carletto S, Cucchiarale G, Gontero P, et al
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes.
Prostate. 2011;71:344-52.
PubMed Text format Related articles Abstract available

February 2011

ROSS AE , Marchionni L, Vuica-Ross M, Cheadle C, et al
Gene expression pathways of high grade localized prostate cancer.
Prostate. 2011 Feb 25. doi: 10.1002/pros.21373.
PubMed Text format Related articles Abstract available

CHIYOMARU T , Tatarano S, Kawakami K, Enokida H, et al
SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
Prostate. 2011 Feb 25. doi: 10.1002/pros.21372.
PubMed Text format Related articles Abstract available

FESINMEYER MD , Kwon EM, Fu R, Ostrander EA, et al
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Prostate. 2011 Feb 25. doi: 10.1002/pros.21370.
PubMed Text format Related articles Abstract available

ZOU J , Milon BC, Desouki MM, Costello LC, et al
hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).
Prostate. 2011 Feb 25. doi: 10.1002/pros.21368.
PubMed Text format Related articles Abstract available

DE NUNZIO C , Freedland SJ, Miano R, Trucchi A, et al
Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy.
Prostate. 2011 Feb 25. doi: 10.1002/pros.21364.
PubMed Text format Related articles Abstract available

CAVAZOS DA , Price RS, Apte SS, Degraffenried LA, et al
Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-kappaB.
Prostate. 2011 Feb 25. doi: 10.1002/pros.21359.
PubMed Text format Related articles Abstract available

ORR B , Vanpoucke G, Grace OC, Smith L, et al
Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia.
Prostate. 2011;71:305-17.
PubMed Text format Related articles Abstract available

MISSOL-KOLKA E , Karbanova J, Janich P, Haase M, et al
Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate.
Prostate. 2011;71:254-67.
PubMed Text format Related articles Abstract available

KOSAKA T , Miyajima A, Shirotake S, Kikuchi E, et al
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
Prostate. 2011 Feb 14. doi: 10.1002/pros.21367.
PubMed Text format Related articles Abstract available

KARKERA J , Steiner H, Li W, Skradski V, et al
The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study.
Prostate. 2011 Feb 14. doi: 10.1002/pros.21362.
PubMed Text format Related articles Abstract available

MISHRA S , Tang Y, Wang L, Degraffenried L, et al
Blockade of transforming growth factor-beta (TGFbeta) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell line.
Prostate. 2011 Feb 14. doi: 10.1002/pros.21361.
PubMed Text format Related articles Abstract available

ABDELBAQI K , Lack N, Guns ET, Kotha L, et al
Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (Ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
Prostate. 2011 Feb 14. doi: 10.1002/pros.21356.
PubMed Text format Related articles Abstract available

THUDI NK , Shu ST, Martin CK, Lanigan LG, et al
Development of a brain metastatic canine prostate cancer cell line.
Prostate. 2011 Feb 14. doi: 10.1002/pros.21341.
PubMed Text format Related articles Abstract available

MAKHOV P , Kutikov A, Golovine K, Uzzo RG, et al
Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: Potential implication for prostate cancer therapy.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21357.
PubMed Text format Related articles Abstract available

AMIRIAN ES , Ittmann MM, Scheurer ME
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21354.
PubMed Text format Related articles Abstract available

HORNDASCH M , Culig Z
SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21353.
PubMed Text format Related articles Abstract available

KAWATA H , Arai S, Nakagawa T, Ishikura N, et al
Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: Optimization from lead compound to CH5137291.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21351.
PubMed Text format Related articles Abstract available

VOIGT S , Huttig F, Koch R, Propping S, et al
Risk factors for incidental prostate cancer-who should not undergo vaporization of the prostate for benign prostate hyperplasia?
Prostate. 2011 Feb 9. doi: 10.1002/pros.21349.
PubMed Text format Related articles Abstract available

SCHICK U , Popowski Y, Nouet P, Bieri S, et al
High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: Hemi-irradiation of prostate cancer.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21347.
PubMed Text format Related articles Abstract available

TOMASZEWSKI JJ , Cummings JL, Parwani AV, Dhir R, et al
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21346.
PubMed Text format Related articles

LIU J , Youn H, Yang J, Du N, et al
G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21345.
PubMed Text format Related articles Abstract available

RAJABI H , Joshi MD, Jin C, Ahmad R, et al
Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
Prostate. 2011 Feb 9. doi: 10.1002/pros.21344.
PubMed Text format Related articles Abstract available

January 2011

TRUMP DL , Payne H, Miller K, de Bono JS, et al
Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer.
Prostate. 2011 Jan 26. doi: 10.1002/pros.21342.
PubMed Text format Related articles Abstract available

SARAFANOV AJ , Todorov TI, Centeno JA, Macias V, et al
Prostate cancer outcome and tissue levels of metal ions.
Prostate. 2011 Jan 26. doi: 10.1002/pros.21339.
PubMed Text format Related articles Abstract available

PEANT B , Forest V, Trudeau V, Latour M, et al
IkappaB-Kinase-epsilon (IKKepsilon/IKKi/IkappaBKepsilon) expression and localization in prostate cancer tissues.
Prostate. 2011 Jan 26. doi: 10.1002/pros.21329.
PubMed Text format Related articles Abstract available

XU S , Weihua Z
Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin.
Prostate. 2011.
PubMed Text format Related articles Abstract available

LAWRENCE MG , Margaryan NV, Loessner D, Collins A, et al
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.
Prostate. 2011.
PubMed Text format Related articles Abstract available

WANG F , Zou YF, Feng XL, Su H, et al
CYP17 gene polymorphisms and prostate cancer risk: A meta-analysis based on 38 independent studies.
Prostate. 2011.
PubMed Text format Related articles Abstract available

GAN L , Wang J, Xu H, Yang X, et al
Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.
Prostate. 2011.
PubMed Text format Related articles Abstract available

OKOBIA MN , Zmuda JM, Ferrell RE, Patrick AL, et al
Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.
Prostate. 2011.
PubMed Text format Related articles Abstract available

SHIMOJO H , Kobayashi M, Kamigaito T, Shimojo Y, et al
Reduced glycosylation of alpha-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.
Prostate. 2011.
PubMed Text format Related articles Abstract available

SHAO P , Ding Q, Qin C, Wang M, et al
Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Prostate. 2011.
PubMed Text format Related articles Abstract available

VO BT , Khan SA
Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: Autocrine effects on cell proliferation and migration.
Prostate. 2011.
PubMed Text format Related articles Abstract available

HSIEH JT , Chen SC, Yu HJ, Chang HC, et al
Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: Implications for chemoprevention of prostate cancer.
Prostate. 2011.
PubMed Text format Related articles Abstract available

GREINER M , Kreutzer B, Lang S, Jung V, et al
Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.
Prostate. 2011.
PubMed Text format Related articles Abstract available

GHADERSOHI A , Sharma S, Zhang S, Azrak RG, et al
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
Prostate. 2011.
PubMed Text format Related articles Abstract available

ALLIOLI N , Vincent S, Vlaeminck-Guillem V, Decaussin-Petrucci M, et al
TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration.
Prostate. 2011.
PubMed Text format Related articles Abstract available

WU LY , Liu T, Grimm AL, Davis WC, et al
Flow cytometric detection of prostate tumor cells using chemoaffinity labels.
Prostate. 2011;71:52-61.
PubMed Text format Related articles Abstract available

UGOLKOV AV , Eisengart LJ, Luan C, Yang XJ, et al
Expression analysis of putative stem cell markers in human benign and malignant prostate.
Prostate. 2011;71:18-25.
PubMed Text format Related articles Abstract available

December 2010

CANACCI AM , Izumi K, Zheng Y, Gordetsky J, et al
Expression of semenogelins I and II and its prognostic significance in human prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LIU M , Suzuki M, Arai T, Sawabe M, et al
A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
Prostate. 2010.
PubMed Text format Related articles Abstract available

GODOY A , Kawinski E, Li Y, Oka D, et al
5alpha-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression.
Prostate. 2010.
PubMed Text format Related articles Abstract available

GOUAZE-ANDERSSON V , Flowers M, Karimi R, Fabrias G, et al
Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HOSHINO K , Ishiguro H, Teranishi JI, Yoshida SI, et al
Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ZHENG Y , Zhou H, Ooi LL, Snir AD, et al
Vitamin D deficiency promotes prostate cancer growth in bone.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LU Y , Zhang Z, Yu H, Zheng SL, et al
Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

SAMUEL-MENDELSOHN S , Inbar M, Weiss-Messer E, Niv-Spector L, et al
Leptin signaling and apoptotic effects in human prostate cancer cell lines.
Prostate. 2010.
PubMed Text format Related articles Abstract available

YANO K
Gene expression correlation analysis predicts involvement of high- and low-confidence risk genes in different stages of prostate carcinogenesis.
Prostate. 2010;70:1746-59.
PubMed Text format Related articles Abstract available

November 2010

KIM J , Koyanagi T, Mochly-Rosen D
PKCdelta activation mediates angiogenesis via NADPH oxidase activity in PC-3 prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ALMASI CE , Brasso K, Iversen P, Pappot H, et al
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

PINSKI J , Xiong S, Wang Q, Stanczyk F, et al
Effect of luteinizing hormone on the steroidogenic pathway in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

XU Z , Bensen JT, Smith GJ, Mohler JL, et al
GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).
Prostate. 2010.
PubMed Text format Related articles Abstract available

BARNABAS N , Xu L, Savera A, Hou Z, et al
Chromosome 8 markers of metastatic prostate cancer in African American men: Gain of the MIR151 gene and loss of the NKX3-1 gene.
Prostate. 2010.
PubMed Text format Related articles Abstract available

APARICIO A , Tzelepi V, Araujo JC, Guo CC, et al
Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles.
Prostate. 2010.
PubMed Text format Related articles Abstract available

GONZALEZ-MORENO O , Boque N, Redrado M, Milagro F, et al
Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage.
Prostate. 2010.
PubMed Text format Related articles Abstract available

PARK MH , Choi MS, Kwak DH, Oh KW, et al
Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-kappaB.
Prostate. 2010.
PubMed Text format Related articles Abstract available

INOUE T , Zakikhani M, David S, Algire C, et al
Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man.
Prostate. 2010;70:1628-35.
PubMed Text format Related articles Abstract available

PRANTL L , Muehlberg F, Navone NM, Song YH, et al
Adipose tissue-derived stem cells promote prostate tumor growth.
Prostate. 2010;70:1709-15.
PubMed Text format Related articles Abstract available

October 2010

ZHU Q , Yang J, Han S, Liu J, et al
Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LIU X , Choi RY, Jawad SM, Arnold JT, et al
Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BASU A , Banerjee H, Rojas H, Martinez SR, et al
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4.
Prostate. 2010.
PubMed Text format Related articles Abstract available

WANG X , Hickey RJ, Malkas LH, Koch MO, et al
Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

SEKINE Y , Suzuki K, Remaley AT
HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion.
Prostate. 2010.
PubMed Text format Related articles Abstract available

CAO DL , Ye DW, Zhang HL, Zhu Y, et al
A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HENSEL JA , Chanda D, Kumar S, Sawant A, et al
LL-37 as a therapeutic target for late stage prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ZUIVERLOON TC , Boormans JL, Trapman J, van Leenders GJ, et al
No evidence of FGFR3 mutations in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

THUDI NK , Martin CK, Murahari S, Shu ST, et al
Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.
Prostate. 2010.
PubMed Text format Related articles Abstract available

WEDEL S , Hudak L, Seibel JM, Juengel E, et al
Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BLANC V , Nariculam J, Munson P, Freeman A, et al
A role for class 3 semaphorins in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

WALTERING KK , Porkka KP, Jalava SE, Urbanucci A, et al
Androgen regulation of micro-RNAs in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BU H , Bormann S, Schafer G, Horninger W, et al
The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
Prostate. 2010.
PubMed Text format Related articles Abstract available

FOLEY R , Marignol L, Keane JP, Lynch TH, et al
Comment on "Androgen-hypersensitive preclinical model of prostate cancer" by Kawata et al.
Prostate. 2010.
PubMed Text format Related articles

WRIGHT JL , Neuhouser ML, Lin DW, Kwon EM, et al
AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.
Prostate. 2010.
PubMed Text format Related articles Abstract available

FOLEY R , Marignol L, Keane JP, Lynch TH, et al
Androgen hypersensitivity in prostate cancer: Molecular perspectives on androgen deprivation therapy strategies.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HEINRICH E , Probst K, Michel MS, Trojan L, et al
Gastrin-releasing peptide: Predictor of castration-resistant prostate cancer?
Prostate. 2010.
PubMed Text format Related articles Abstract available

LIU X , Cheng I, Plummer SJ, Suarez BK, et al
Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.
Prostate. 2010.
PubMed Text format Related articles Abstract available

FORTMULLER K , Alt K, Gierschner D, Wolf P, et al
Effective targeting of prostate cancer by lymphocytes redirected by a PSMA x CD3 bispecific single-chain diabody.
Prostate. 2010.
PubMed Text format Related articles Abstract available

September 2010

SHI XB , Xue L, Ma AH, Tepper CG, et al
miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KOSTI O , Xu X, Veenstra TD, Hsing AW, et al
Urinary estrogen metabolites and prostate cancer risk: A pilot study.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LI B , Shi XB, Nori D, Chao CK, et al
Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

MAGI-GALLUZZI C , Tsusuki T, Elson P, Simmerman K, et al
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients.
Prostate. 2010.
PubMed Text format Related articles Abstract available

NOGUCHI M , Uemura H, Naito S, Akaza H, et al
A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

SUN J , Kader AK, Hsu FC, Kim ST, et al
Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

VERHAEGH GW , de Jong AS, Smit FP, Jannink SA, et al
Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients.
Prostate. 2010.
PubMed Text format Related articles Abstract available

TAKAHARA K , Tearle H, Ghaffari M, Gleave ME, et al
Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression.
Prostate. 2010.
PubMed Text format Related articles Abstract available

FLEISCHMANN A , Rocha C, Schobinger S, Seiler R, et al
Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HELFAND BT , Kan D, Modi P, Catalona WJ, et al
Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BOUCHAL J , Santer FR, Hoschele PP, Tomastikova E, et al
Transcriptional coactivators p300 and CBP stimulate estrogen receptor-beta signaling and regulate cellular events in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HEAPHY CM , Fleet TM, Treat EG, Lee SJ, et al
Organ-wide telomeric status in diseased and disease-free prostatic tissues.
Prostate. 2010;70:1471-9.
PubMed Text format Related articles Abstract available

PREECE DM , Harvey JM, Bentel JM, Thomas MA, et al
ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ZHANG HL , Yang LF, Zhu Y, Yao XD, et al
Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy.
Prostate. 2010.
PubMed Text format Related articles Abstract available

CHADHA MK , Fakih M, Muindi J, Tian L, et al
Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ZOLOCHEVSKA O , Figueiredo ML
Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LI H , Zhang H, Wei G, Cai Q, et al
Tumor cell group via phospholipase A(2) is involved in prostate cancer development.
Prostate. 2010.
PubMed Text format Related articles Abstract available

TOBIUME M , Yamada Y, Nakamura K, Aoki S, et al
Significant prognostic factor of immunohistochemical HER-2 expression using initial prostate biopsy specimens with M1b prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

MAHAJAN K , Challa S, Coppola D, Lawrence H, et al
Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.
Prostate. 2010;70:1274-85.
PubMed Text format Related articles Abstract available

CAPITANIO U , Briganti A, Gallina A, Suardi N, et al
Predictive models before and after radical prostatectomy.
Prostate. 2010;70:1371-8.
PubMed Text format Related articles Abstract available

KURODA K , Liu H, Kim S, Guo M, et al
Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.
Prostate. 2010;70:1286-94.
PubMed Text format Related articles Abstract available

August 2010

MINNER S , Wittmer C, Graefen M, Salomon G, et al
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LIN J , Haffner MC, Zhang Y, Lee BH, et al
Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BAND PR , Abanto Z, Bert J, Lang B, et al
Prostate cancer risk and exposure to pesticides in British Columbia Farmers.
Prostate. 2010.
PubMed Text format Related articles Abstract available

PIERCONTI F , Martini M, Pinto F, Cenci T, et al
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KAI L , Wang J, Ivanovic M, Chung YT, et al
Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1).
Prostate. 2010.
PubMed Text format Related articles Abstract available

WANG Y , Ray AM, Johnson EK, Zuhlke KA, et al
Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: The flint men's health study.
Prostate. 2010.
PubMed Text format Related articles Abstract available

YOKOMIZO A , Shiota M, Kashiwagi E, Kuroiwa K, et al
Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

WIECKOWSKI E , Chatta GS, Mailliard RM, Gooding W, et al
Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LIU H , Wang B, Han C
Meta-analysis of genome-wide and replication association studies on prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

JAYADEVAPPA R , Schwartz JS, Chhatre S, Gallo JJ, et al
The burden of out-of-pocket and indirect costs of prostate cancer.
Prostate. 2010;70:1255-64.
PubMed Text format Related articles Abstract available

GRAVINA GL , Marampon F, Di Staso M, Bonfili P, et al
5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors.
Prostate. 2010;70:1166-78.
PubMed Text format Related articles Abstract available

July 2010

JOSSON S , Anderson CS, Sung SY, Johnstone PA, et al
Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy.
Prostate. 2010.
PubMed Text format Related articles Abstract available

RIGAU M , Morote J, Mir MC, Ballesteros C, et al
PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine.
Prostate. 2010.
PubMed Text format Related articles Abstract available

TRIPATHI M , Potdar AA, Yamashita H, Weidow B, et al
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ZHANG C , Soori M, Miles FL, Sikes RA, et al
Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

CUFFE S , Dowling CM, Claffey J, Pampillon C, et al
Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
Prostate. 2010.
PubMed Text format Related articles Abstract available

June 2010

GUPTA S , Wang Y, Ramos-Garcia R, Shevrin D, et al
Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice.
Prostate. 2010.
PubMed Text format Related articles Abstract available

COMPERAT E , Roupret M, Drouin SJ, Camparo P, et al
Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy.
Prostate. 2010.
PubMed Text format Related articles Abstract available

LOUIS SN , Chow L, Rezmann L, Krezel MA, et al
Expression and function of ATIP/MTUS1 in human prostate cancer cell lines.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KOJIMA K , Fujita Y, Nozawa Y, Deguchi T, et al
MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Prostate. 2010.
PubMed Text format Related articles Abstract available

May 2010

KONIJETI R , Henning S, Moro A, Sheikh A, et al
Chemoprevention of prostate cancer with lycopene in the TRAMP model.
Prostate. 2010.
PubMed Text format Related articles Abstract available

PICKARD MR , Edwards SE, Cooper CS, Williams GT, et al
Apoptosis regulators Fau and Bcl-G are down-regulated in prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KIM HS , Presti JC Jr, Aronson WJ, Terris MK, et al
Glycemic control and prostate cancer progression: Results from the SEARCH database.
Prostate. 2010.
PubMed Text format Related articles Abstract available

HOLT SK , Kwon EM, Koopmeiners JS, Lin DW, et al
Vitamin D pathway gene variants and prostate cancer prognosis.
Prostate. 2010.
PubMed Text format Related articles Abstract available

PFEIFFER MJ , Mulders PF, Schalken JA
An in vitro model for preclinical testing of endocrine therapy combinations for prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

TASSIDIS H , Culig Z, Wingren AG, Harkonen P, et al
Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KYRDALEN AE , Dahl AA, Hernes E, Hem E, et al
Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs.
Prostate. 2010.
PubMed Text format Related articles Abstract available

KALLBERG E , Wikstrom P, Bergh A, Ivars F, et al
Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
Prostate. 2010.
PubMed Text format Related articles Abstract available

EVREN S , Dermen A, Lockwood G, Fleshner N, et al
Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): A tissue microarray study (TMA).
Prostate. 2010.
PubMed Text format Related articles Abstract available

April 2010

MUSENDE AG , Eberding A, Jia W, Ramsay E, et al
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
Prostate. 2010.
PubMed Text format Related articles Abstract available

ALT K , Wiehr S, Ehrlichmann W, Reischl G, et al
High-resolution animal PET imaging of prostate cancer xenografts with three different (64)Cu-labeled antibodies against native cell-adherent PSMA.
Prostate. 2010.
PubMed Text format Related articles Abstract available

TAKIZAWA I , Nishiyama T, Hara N, Isahaya E, et al
Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu.
Prostate. 2010.
PubMed Text format Related articles Abstract available

STEIN M , Lin H, Jeyamohan C, Dvorzhinski D, et al
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies.
Prostate. 2010.
PubMed Text format Related articles Abstract available

BERGUM C , List K
Loss of the matriptase inhibitor HAI-2 during prostate cancer progression.
Prostate. 2010.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: